Zobrazeno 1 - 10
of 711
pro vyhledávání: '"Rouce, R."'
Autor:
Auletta JJ; NMDP, Minneapolis, MN; Hematology/Oncology/Blood and Marrow Transplant and Infectious Diseases; Nationwide Children's Hospital, Columbus, OH. Electronic address: jaulett3@nmdp.org., Holter-Chakrabarty J; University of Oklahoma Health Sciences Center, Oklahoma City, OK., Munshi P; University of Pennsylvania, Philadelphia, PA., Wall S; The Ohio State University Comprehensive Cancer Center., Khera N; Mayo Clinic, Phoenix, AZ., Knutson J; NMDP, Minneapolis, MN., Gomez-Arteaga A; Weill Cornell Medicine, New York, NY., Hall AG; Seattle Children's Hospital, Seattle, WA., Foster J; NMDP, Minneapolis, MN., Ruffin A; NMDP, Minneapolis, MN., Robb D; NMDP, Minneapolis, MN., Nemecek E; Oregon Health Sciences University, Portland, OR., Rouce R; Texas Children's Hospital, Baylor College of Medicine, Houston, TX., Davies SM; Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.
Autor:
Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Division of Bone Marrow Transplant and Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu., Bollard CM; Center for Cancer and Immunology Research and Department of Pediatrics, Children's National Hospital and The George Washington University, Washington, DC, USA., Goodman N; KidsVCancer, Washington, DC, USA., Carr C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Gardner R; St. Jude Children's Research Hospital, Memphis, TN, USA., Rouce R; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX, USA., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Stoner R; Exthymic, San Diego, CA, USA., Urnov FD; Innovative Genomics Institute, University of California at Berkeley, Berkeley, CA, USA., Wayne AS; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Park J; St. Jude Children's Research Hospital, Memphis, TN, USA., Kohn DB; Departments of Microbiology, Immunology & Molecular Genetics; Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 1836-1846. Date of Electronic Publication: 2024 Jun 17.
Autor:
Talleur AC; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: atalleur@stjude.org., Fabrizio VA; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplant, Children's Hospital Colorado/University of Colorado Anschutz, Aurora, Colorado., Aplenc R; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Grupp SA; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Mackall C; Department of Pediatrics, Department of Medicine, Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford University, Stanford, California., Majzner R; Dana-Farber Cancer Institute, Boston, Massachusetts., Nguyen R; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rouce R; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas., Moskop A; Division of Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, Wisconsin., McNerney KO; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun; Vol. 30 (6), pp. 565-579. Date of Electronic Publication: 2024 Apr 07.
Autor:
Badr H; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: hoda.badr@bcm.edu., Rouce R; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. Electronic address: rouce@bcm.edu., Scheurer ME; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Lulla P; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Mims M; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Reddy P; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: pavan.reddy@bcm.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2007-2010. Date of Electronic Publication: 2023 Oct 26.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Allen J; Spark Therapeutics, Inc., Philadelphia, PA 19104, USA., Berry D; Sarepta Therapeutics, Inc., Cambridge, MA 02142, USA., Cook F; REGENXBIO Inc., Rockville, MD 20850, USA., Hume A; Emerging Therapy Solutions, Bloomington, MN 55425, USA., Rouce R; Center for Cell and Gene Therapy, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Srirangam A; Bristol Myer Squibb Company, Washington, DC 20004, USA., Wellman J; Akouos, Inc., a Wholly Owned Subsidiary of Eli Lilly and Company, Boston, MA 02210, USA., McCombs C; American Society of Gene and Cell Therapy, Waukesha, WI 53186, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 May 16; Vol. 29, pp. 513-521. Date of Electronic Publication: 2023 May 16 (Print Publication: 2023).
Autor:
Ramos, C. A., Quach, D. H., Lulla, P. D., Rouce, R. H., Sharma, S., Ganesh, H. R., Nouraee, N., Briones, Y. D., Becerra‐Dominguez, L., Thakkar, S. G., Mehta, B., Perconti, S., Hsieh, E. M., Zhang, H., Grilley, B. J., Lapteva, N., Brenner, M. K., Heslop, H. E., Rooney, C. M.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p83-85, 3p
Autor:
Karsenty, C., Kim, T., Gulati, N., Shapiro, M., Sher, A., Curry, C., Brackett, J., Agrusa, J., Eckstein, O., Margolin, J., Rouce, R., Dreyer, Z., Dajac, J., Chanroo, T., Grim, Austyn T., Peckham-Gregory, Erin L., Ozuah, Nmazuo W., McClain, Kenneth L., Allen, C., El-Mallawany, N., Kamdar, Kala Y.
Publikováno v:
In Leukemia Research October 2022 121 Supplement:S58-S58
Autor:
Gulati, N., Eckstein, O., Agrusa, J., Kamdar, K., Rouce, R., Curry, C., Fisher, K., Forbes, L., Grim, A., Peckham-Gregory, E., McClain, K., Allen, C., El-Mallawany, N.
Publikováno v:
In Leukemia Research October 2022 121 Supplement:S6-S7
Autor:
Ramos, C.A., Grilley, B., Heslop, H.E., Gee, A.P., Savoldo, B., Robertson, C.S., Rouce, R., Dotti, G., Wu, M.-F., Dakhova, O., Liu, H., Mei, Z., Kamble, R.T., Zhang, H., Rooney, C.M., Carrum, G., Reyna, A., Brenner, M.K., Vyas, G., Narala, N., Mehta, B.
Second-generation (2G) chimeric antigen receptors (CARs) targeting CD19 are highly active against B cell malignancies, but it is unknown whether any of the costimulatory domains incorporated in the CAR have superior activity to others. Because CD28 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a12eab48f671a5b499105f8d47da8e65